Development of a Label-Free LC-MS/MS-Based Glucosylceramide Synthase Assay and Its Application to Inhibitors Screening for Ceramide-Related Diseases

다국어 초록 (Multilingual Abstract)

Ceramide metabolism is known to be an essential etiology for various diseases, such as atopic dermatitis and Gaucher disease.
Glucosylceramide synthase (GCS) is a key enzyme for the synthesis of glucosylceramide (GlcCer), which is a main ceramide metabolism pathway in mammalian cells. In this article, we developed a liquid chromatography-tandem mass spectrometry (LCMS/ MS) method to determine GCS activity using synthetic non-natural sphingolipid C8-ceramide as a substrate. The reaction products, C8-GlcCer for GCS, could be separated on a C18 column by reverse-phase high-performance liquid chromatography (HPLC). Quantification was conducted using the multiple reaction monitoring (MRM) mode to monitor the precursor-to-product ion transitions of m/z 588.6 → 264.4 for C8-GlcCer at positive ionization mode. The calibration curve was established over the range of 0.625-160 ng/mL, and the correlation coefficient was larger than 0.999. This method was successfully applied to detect GCS in the human hepatocellular carcinoma cell line (HepG2 cells) and mouse peripheral blood mononuclear cells. We also evaluated the inhibition degree of a known GCS inhibitor 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) on GCS enzymatic activity and proved that this method could be successfully applied to GCS inhibitor screening of preventive and therapeutic drugs for ceramide metabolism diseases, such as atopic dermatitis and Gaucher disease.

참고문헌 (Reference)

1 Shawky RM, "Treatment options for patients with Gaucher disease" 17 : 281-285, 2016

2 Radin NS, "Treatment of Gaucher disease with an enzyme inhibitor" 13 : 153-157, 1996

3 Limgala RP, "Time of initiating enzyme replacement therapy affects immune abnormalities and disease severity in patients with Gaucher disease" 11 : e0168135-, 2016

4 Kartal Yandim M, "Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer" 71 : 13-20, 2013

5 Ekiz HA, "Therapeutic applications of bioactive sphingolipids in hematological malignancies" 127 : 1497-1506, 2010

6 Duclos RI, "The total syntheses of D-erythro-sphingosine, N-palmitoylsphingosine(ceramide), and glucosylceramide(cerebroside)via an azidosphingosine analog" 111 : 111-138, 2001

7 Kolesnick R, "The therapeutic potential of modulating the ceramide/sphingomyelin pathway" 110 : 3-8, 2002

8 Sietsma H, "The involvement of sphingolipids in multidrug resistance" 181 : 153-162, 2001

9 Tuuf J, "The intermembrane ceramide transport catalyzed by CERT is sensitive to the lipid environment" 1808 : 229-235, 2011

10 Degroote S, "The cell biology of glycosphingolipids" 15 : 375-387, 2004

11 Senchenkov A, "Targeting ceramide metabolism-a strategy for overcoming drug resistance" 93 : 347-357, 2001

12 Miura T, "Synthesis and evaluation of morpholino-and pyrrolidinosphingolipids as inhibitors of glucosylceramide synthase" 6 : 1481-1489, 1998

13 Hakomori SI, "Structure and function of glycosphingolipids and sphingolipids : recollections and future trends" 1780 : 325-346, 2008

14 Abe A, "Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth" 36 : 611-621, 1995

15 van Meer G, "Sphingolipid transport in eukaryotic cells" 1486 : 145-170, 2000

16 Yoshizaki F, "Role of glycosphingolipid-enriched microdomains in innate immunity : microdomain-dependent phagocytic cell functions" 1780 : 383-392, 2008

17 Choi MJ, "Role of ceramides in barrier function of healthy and diseased skin" 6 : 215-223, 2005

18 Wang J, "Potential mechanisms involved in ceramide-induced apoptosis in human colon cancer HT29 cells" 22 : 76-85, 2009

19 Xie P, "Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells" 32 : 475-480, 2008

20 Liu YY, "Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells" 45 : 933-940, 2004

21 Vielhaber G, "Localization of ceramide and glucosylceramide in human epidermis by immunogold electron microscopy" 117 : 1126-1136, 2001

22 Chatterjee S, "Lactosylceramide synthase as a therapeutic target to mitigate multiple human diseases in animal models" 749 : 153-169, 2012

23 Mishra S, "Lactosylceramide promotes hypertrophy through ROS generation and activation of ERK1/2 in cardiomyocytes" 24 : 518-531, 2014

24 Abe A, "Improved inhibitors of glucosylceramide synthase" 111 : 191-196, 1992

25 Bleicher RJ, "Glucosylceramide synthase and apoptosis" 1585 : 172-178, 2002

26 Chujor CS, "Glucosylceramide synthase activity in murine epidermis : quantitation, localization, regulation, and requirement for barrier homeostasis" 39 : 277-285, 1998

27 Bennett LL, "Gaucher disease and its treatment options" 47 : 1182-1193, 2013

28 Nagral A, "Gaucher disease" 4 : 37-50, 2014

29 Ichikawa S, "Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis" 93 : 12654-, 1996

30 Basu S, "Enzymatic synthesis of glucocerebroside by a glucosyltransferase from embryonic chicken brain" 248 : 1388-1394, 1973

31 Maunula S, "Differences in the domain forming properties of N-palmitoylated neutral glycosphingolipids in bilayer membranes" 1768 : 336-345, 2007

32 Zheng W, "Ceramides and other bioactive sphingolipid backbones in health and disease : lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy" 1758 : 1864-1884, 2006

33 Liu YY, "Ceramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance" 117 : 59-89, 2013

34 Mizutani Y, "Ceramide biosynthesis in keratinocyte and its role in skin function" 91 : 784-790, 2009

35 Di Sano F, "Antisense to glucosylceramide synthase in human neuroepithelioma affects cell growth but not apoptosis" 9 : 693-695, 2002

36 Vunnam RR, "Analogs of ceramide that inhibit glucocerebroside synthetase in mouse brain" 26 : 265-278, 1980

37 Hayashi Y, "A sensitive and reproducible assay to measure the activity of glucosylceramide synthase and lactosylceramide synthase using HPLC and fluorescent substrates" 345 : 181-186, 2005

38 Imokawa G, "A possible mechanism underlying the ceramide deficiency in atopic dermatitis : expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide" 55 : 1-9, 2009

39 Hospattankar AV, "A 2-phase liquid scintillation assay for glycolipid synthetases" 16 : 764-766, 1981